Opioid Prescribing Recommendations After Mohs Micrographic Surgery and Reconstruction: A Delphi Consensus.


Journal

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
ISSN: 1524-4725
Titre abrégé: Dermatol Surg
Pays: United States
ID NLM: 9504371

Informations de publication

Date de publication:
01 02 2021
Historique:
pubmed: 10 8 2020
medline: 27 4 2021
entrez: 10 8 2020
Statut: ppublish

Résumé

Prescription opioids play a large role in the opioid epidemic. Even short-term prescriptions provided postoperatively can lead to dependence. To provide opioid prescription recommendations after Mohs micrographic surgery (MMS) and reconstruction. This was a multi-institutional Delphi consensus study consisting of a panel of members of the American College of Mohs Surgery from various practice settings. Participants were first asked to describe scenarios in which they prescribe opioids at various frequencies. These scenarios then underwent 2 Delphi ratings rounds that aimed to identify situations in which opioid prescriptions should, or should not, be routinely prescribed. Consensus was set at ≥80% agreement. Prescription recommendations were then distributed to the panelists for feedback and approval. Twenty-three Mohs surgeons participated in the study. There was no scenario in which consensus was met to routinely provide an opioid prescription. However, there were several scenarios in which consensus were met to not routinely prescribe an opioid. Opioids should not be routinely prescribed to every patient undergoing MMS. Prescription recommendations for opioids after MMS and reconstruction may decrease the exposure to these drugs and help combat the opioid epidemic.

Sections du résumé

BACKGROUND
Prescription opioids play a large role in the opioid epidemic. Even short-term prescriptions provided postoperatively can lead to dependence.
OBJECTIVE
To provide opioid prescription recommendations after Mohs micrographic surgery (MMS) and reconstruction.
METHODS
This was a multi-institutional Delphi consensus study consisting of a panel of members of the American College of Mohs Surgery from various practice settings. Participants were first asked to describe scenarios in which they prescribe opioids at various frequencies. These scenarios then underwent 2 Delphi ratings rounds that aimed to identify situations in which opioid prescriptions should, or should not, be routinely prescribed. Consensus was set at ≥80% agreement. Prescription recommendations were then distributed to the panelists for feedback and approval.
RESULTS
Twenty-three Mohs surgeons participated in the study. There was no scenario in which consensus was met to routinely provide an opioid prescription. However, there were several scenarios in which consensus were met to not routinely prescribe an opioid.
CONCLUSION
Opioids should not be routinely prescribed to every patient undergoing MMS. Prescription recommendations for opioids after MMS and reconstruction may decrease the exposure to these drugs and help combat the opioid epidemic.

Identifiants

pubmed: 32769528
pii: 00042728-202102000-00003
doi: 10.1097/DSS.0000000000002551
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

167-169

Informations de copyright

Copyright © 2020 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.

Références

Volkow ND. Prescription Opioid and Heroin Abuse. 2014. Available at: https://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2016/prescription-opioid-heroin-abuse#2 . Accessed August 2, 2017.
Scholl L, Seth P, Kariisa M, Wilson N, et al. Drug and opioid-involved overdose deaths—United States, 2013-2017. MMWR-Morbidity Mortality Weekly Rep 2019;67:1419–27.
Seth P, Rudd RA, Noonan RK, Haegerich TM. Quantifying the epidemic of prescription opioid overdose deaths. Am J Public Health 2018;108:500–2.
Feng H, Kakpovbia E, Petriceks AP, Feng PW, et al. Characteristics of opioid prescriptions by Mohs surgeons in the medicare population. Dermatol Surg 2020;46:335–40.
Sniezek PJ, Brodland DG, Zitelli JA. A randomized controlled trial comparing acetaminophen, acetaminophen and ibuprofen, and acetaminophen and codeine for postoperative pain relief after Mohs surgery and cutaneous reconstruction. Dermatol Surg 2011;37:1007–13.
Chen AF, Landy DC, Kumetz E, Smith G, et al. Prediction of postoperative pain after Mohs micrographic surgery with 2 validated pain anxiety scales. Dermatol Surg 2015;41:40–7.
Limthongkul B, Samie F, Humphreys TR. Assessment of postoperative pain after Mohs micrographic surgery. Dermatol Surg 2013;39:857–63.
Firoz BF, Goldberg LH, Arnon O, Mamelak AJ. An analysis of pain and analgesia after Mohs micrographic surgery. J Am Acad Dermatol 2010;63:79–86.
Saco M, Golda N. Optimal timing of post-operative pharmacologic pain control in Mohs micrographic surgery: a prospective cohort study. J Am Acad Dermatol 2020;82:495–97.
Harris K, Curtis J, Larsen B, Calder S, et al. Opioid pain medication use after dermatologic surgery A prospective observational study of 212 dermatologic surgery patients. Jama Dermatol 2013;149:317–21.
Merritt BG, Lee NY, Brodland DG, Zitelli JA, et al. The safety of Mohs surgery: a prospective multicenter cohort study. J Am Acad Dermatol 2012;67:1302–9.
Donigan JM, Franco AI, Stoddard GJ, Hedderman A, et al. Opioid prescribing patterns after micrographic surgery: a follow-up retrospective chart review. Dermatol Surg 2019;45:508–13.
Helmer O. Analysis of the Future: the Delphi Method. RAND Corporation; 1967. Available at: https://www.rand.org/pubs/papers/P3558.html . Accessed September 16, 2019.
Chang AK, Bijur PE, Esses D, Barnaby DP, et al. Effect of a single dose of oral opioid and nonopioid analgesics on acute extremity pain in the emergency department: a randomized clinical trial. JAMA 2017;318:1661–7.
St Charles CS, Matt BH, Hamilton MM, Katz BP. A comparison of ibuprofen versus acetaminophen with codeine in the young tonsillectomy patient. Otolaryngol Head Neck Surg 1997;117:76–82.

Auteurs

Jessica M Donigan (JM)

Department of Dermatology, University of Utah, Salt Lake City, Utah.

Divya Srivastava (D)

Department of Dermatology, University of Texas Southwestern, Dallas, Texas.

Ian Maher (I)

Department of Dermatology, University of Minnesota, Minneapolis, Minnesota.

Mark Abdelmalek (M)

Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

Anna A Bar (AA)

Department of Dermatology, Oregon Health and Science University, Portland, Oregon.

Travis W Blalock (TW)

Department of Dermatology, Emory University, Atlanta, Georgia.

Jeremy S Bordeaux (JS)

Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio.

David G Brodland (DG)

Zitelli & Brodland, P.C. Skin Cancer Center, Pittsburgh, Pennsylvania.
Zitelli & Brodland, P.C. Skin Cancer Center, Clairton, Pennsylvania.
Departments of Dermatology, Otolaryngology, and Plastic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.

Bryan T Carroll (BT)

Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio.

Martha Laurin Council (ML)

Division of Dermatology, Washington University School of Medicine in St. Louis, St. Louis, Missouri.

Keith Duffy (K)

Department of Dermatology, University of Utah, Salt Lake City, Utah.

Ramin Fathi (R)

Phoenix Surgical Dermatology Group, LLC, Phoenix, Arizona.

Nicholas Golda (N)

Department of Dermatology, University of Missouri, Columbia, Missouri.

Hillary Johnson-Jahangir (H)

Department of Dermatology, University of Iowa, Iowa City, Iowa.

Sailesh Konda (S)

Department of Dermatology, University of Florida, Gainesville, Florida.

Justin J Leitenberger (JJ)

Department of Dermatology, Oregon Health and Science University, Portland, Oregon.

Molly Moye (M)

Forefront Dermatology, Louisville, Kentucky.

Jenny L Nelson (JL)

Avera Medical Group Dermatology Sioux Falls, Sioux Falls, South Dakota.

Vishal A Patel (VA)

Department of Dermatology, The George Washington University School of Medicine & Health Sciences, Washington, District of Columbia.

Joseph J Shaffer (JJ)

Dermatology Consultants, St. Paul, Minnesota.

Razieh Soltani-Arabshahi (R)

Department of Dermatology, University of Southern California Keck School of Medicine, Los Angeles, California.

Payam Tristani-Firouzi (P)

Revere Health, Provo, Utah; and.

Amanda J Tschetter (AJ)

Dermatology Specialists, Edina, Minnesota.

Rajiv I Nijhawan (RI)

Department of Dermatology, University of Texas Southwestern, Dallas, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH